BamSEC and AlphaSense Join Forces
Learn More

Phio Pharmaceuticals Corp.

NASDAQ: PHIO    
Share price (1/8/25): $1.69    
Market cap (1/8/25): $1.783 million
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.1
from 8-K 31 pages Securities Purchase Agreement
12/34/56
EX-10.1
from 8-K 31 pages Securities Purchase Agreement
12/34/56
EX-10.1
from 8-K 9 pages Material contract
12/34/56
EX-10.1
from 8-K 8 pages Holder of Common Stock Purchase Warrants Re: Inducement Offer to Exercise Common Stock Purchase Warrants Dear Holder
12/34/56
EX-10.1
from 8-K 20 pages Phio Pharmaceuticals Corp. 2020 Long Term Incentive Plan
12/34/56
EX-10.1
from 8-K 18 pages Purchase Agreement
12/34/56
EX-10.1
from 8-K 7 pages December 6, 2023 Holder of Common Stock Purchase Warrants Re: Inducement Offer to Exercise Common Stock Purchase Warrants Dear Holder
12/34/56
EX-10.2
from 10-Q 6 pages Phio Pharmaceuticals Corp. 2020 Long Term Incentive Plan Nonqualified Stock Option Award Agreement
12/34/56
EX-10.1
from 10-Q 16 pages Phio Pharmaceuticals Corp. 2020 Long Term Incentive Plan
12/34/56
EX-10.1
from 8-K 16 pages Phio Pharmaceuticals Corp. 2020 Long Term Incentive Plan
12/34/56
EX-10.3
from 8-K 14 pages Registration Rights Agreement
12/34/56
EX-10.2
from 8-K 32 pages Securities Purchase Agreement
12/34/56
EX-10.1
from 8-K 32 pages Securities Purchase Agreement
12/34/56
EX-10.1
from 8-K 36 pages Securities Purchase Agreement
12/34/56
EX-10.11
from 10-K 7 pages Separation Agreement and General Release of Claims
12/34/56
EX-10.2
from 10-K 38 pages 1. Definitions
12/34/56
EX-10.1
from 8-K 11 pages Employment Agreement
12/34/56
EX-10.1
from 8-K 5 pages Phio Pharmaceuticals Corp. Series D Preferred Stock Subscription and Investment Representation Agreement
12/34/56
EX-10.3
from 10-K 4 pages Phio Pharmaceuticals Corp. 2020 Long Term Incentive Plan Grant Notice for Restricted Stock Unit Award
12/34/56
EX-10.1
from 8-K 26 pages Securities Purchase Agreement
12/34/56